Digital Content 
NEWS #PharmaBuzz
11 Jan 2022
// PHARMATIMES
https://www.pharmatimes.com/news/european_commission_approves_cystic_fibrosis_treatment_for_six_to_11-year-olds_1386105
19 Nov 2021
// BUSINESSWIRE
21 Dec 2020
// BIOSPACE
https://www.biospace.com/article/releases/vertex-announces-fda-approvals-of-trikafta-elexacaftor-tezacaftor-ivacaftor-and-ivacaftor-symdeko-tezacaftor-ivacaftor-and-ivacaftor-and-kalydeco-ivacaftor-for-use-in-people-with-cf-with-certain-rare-mutations/?s=74
01 Dec 2020
// Selina McKee PHARMATIMES
http://www.pharmatimes.com/news/symkevikalydeco_cleared_for_use_in_young_cf_patients_1358460
24 Sep 2020
// BUSINESSWIRE
https://www.businesswire.com/news/home/20200924005175/en/Vertex-to-Present-New-Data-at-European-and-North-American-Virtual-Cystic-Fibrosis-Conferences-Highlighting-Long-Term-Use-of-CFTR-Modulators
23 Sep 2020
// PRESS RELEASE
https://icer-review.org/announcements/icer-issues-final-report-and-policy-recommendations-on-treatments-for-cystic-fibrosis/
Share 